| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |